CN107440107A - 一种供妊娠反应人群食用含短肽的特殊膳食用食品配方 - Google Patents
一种供妊娠反应人群食用含短肽的特殊膳食用食品配方 Download PDFInfo
- Publication number
- CN107440107A CN107440107A CN201710841208.XA CN201710841208A CN107440107A CN 107440107 A CN107440107 A CN 107440107A CN 201710841208 A CN201710841208 A CN 201710841208A CN 107440107 A CN107440107 A CN 107440107A
- Authority
- CN
- China
- Prior art keywords
- food
- vitamin
- small peptide
- concentrated extract
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 76
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 68
- 230000035935 pregnancy Effects 0.000 title claims abstract description 46
- 238000006243 chemical reaction Methods 0.000 title claims abstract description 45
- 235000005911 diet Nutrition 0.000 title claims abstract description 19
- 230000037213 diet Effects 0.000 title claims abstract description 17
- 239000000284 extract Substances 0.000 claims abstract description 61
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 23
- 239000011707 mineral Substances 0.000 claims abstract description 23
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 19
- 235000008397 ginger Nutrition 0.000 claims abstract description 19
- 241000411851 herbal medicine Species 0.000 claims abstract description 18
- 235000004347 Perilla Nutrition 0.000 claims abstract description 16
- 229920001542 oligosaccharide Polymers 0.000 claims abstract description 15
- 150000002482 oligosaccharides Chemical class 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 15
- 244000223014 Syzygium aromaticum Species 0.000 claims abstract description 13
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims abstract description 13
- 229940088594 vitamin Drugs 0.000 claims abstract description 12
- 229930003231 vitamin Natural products 0.000 claims abstract description 12
- 235000013343 vitamin Nutrition 0.000 claims abstract description 12
- 239000011782 vitamin Substances 0.000 claims abstract description 12
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 11
- 235000009421 Myristica fragrans Nutrition 0.000 claims abstract description 7
- 239000001702 nutmeg Substances 0.000 claims abstract description 7
- 210000000582 semen Anatomy 0.000 claims abstract description 6
- 150000001875 compounds Chemical class 0.000 claims abstract description 5
- 244000270834 Myristica fragrans Species 0.000 claims abstract description 4
- 244000124853 Perilla frutescens Species 0.000 claims abstract 2
- 244000273928 Zingiber officinale Species 0.000 claims abstract 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 14
- 241000251468 Actinopterygii Species 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 8
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 8
- 108010038807 Oligopeptides Proteins 0.000 claims description 8
- 102000015636 Oligopeptides Human genes 0.000 claims description 8
- 108010073771 Soybean Proteins Proteins 0.000 claims description 8
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 8
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical group [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 7
- 239000011575 calcium Substances 0.000 claims description 7
- 229910052791 calcium Inorganic materials 0.000 claims description 7
- 229910052742 iron Inorganic materials 0.000 claims description 7
- 229940001941 soy protein Drugs 0.000 claims description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 6
- 239000011701 zinc Substances 0.000 claims description 6
- 229910052725 zinc Inorganic materials 0.000 claims description 6
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 4
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 4
- 241000237502 Ostreidae Species 0.000 claims description 4
- 108010084695 Pea Proteins Proteins 0.000 claims description 4
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 4
- 229930003268 Vitamin C Natural products 0.000 claims description 4
- 229930003316 Vitamin D Natural products 0.000 claims description 4
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 4
- 229960000304 folic acid Drugs 0.000 claims description 4
- 239000011724 folic acid Substances 0.000 claims description 4
- 235000019152 folic acid Nutrition 0.000 claims description 4
- 229960003512 nicotinic acid Drugs 0.000 claims description 4
- 239000011664 nicotinic acid Substances 0.000 claims description 4
- 235000001968 nicotinic acid Nutrition 0.000 claims description 4
- 235000020636 oyster Nutrition 0.000 claims description 4
- 235000019702 pea protein Nutrition 0.000 claims description 4
- 235000019155 vitamin A Nutrition 0.000 claims description 4
- 239000011719 vitamin A Substances 0.000 claims description 4
- 239000011691 vitamin B1 Substances 0.000 claims description 4
- 239000011715 vitamin B12 Substances 0.000 claims description 4
- 235000019154 vitamin C Nutrition 0.000 claims description 4
- 239000011718 vitamin C Substances 0.000 claims description 4
- 235000019166 vitamin D Nutrition 0.000 claims description 4
- 239000011710 vitamin D Substances 0.000 claims description 4
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 4
- 229940045997 vitamin a Drugs 0.000 claims description 4
- 229940046008 vitamin d Drugs 0.000 claims description 4
- 241000251511 Holothuroidea Species 0.000 claims description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 3
- 229930003427 Vitamin E Natural products 0.000 claims description 3
- 102000007544 Whey Proteins Human genes 0.000 claims description 3
- 108010046377 Whey Proteins Proteins 0.000 claims description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 3
- 239000011716 vitamin B2 Substances 0.000 claims description 3
- 235000019165 vitamin E Nutrition 0.000 claims description 3
- 239000011709 vitamin E Substances 0.000 claims description 3
- 229940046009 vitamin E Drugs 0.000 claims description 3
- 235000021119 whey protein Nutrition 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 2
- 239000000460 chlorine Substances 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 229910052802 copper Inorganic materials 0.000 claims description 2
- 239000010949 copper Substances 0.000 claims description 2
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 2
- 150000003271 galactooligosaccharides Chemical class 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 2
- 239000011777 magnesium Substances 0.000 claims description 2
- 229910052749 magnesium Inorganic materials 0.000 claims description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 2
- 239000011574 phosphorus Substances 0.000 claims description 2
- 229910052698 phosphorus Inorganic materials 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- 229910052711 selenium Inorganic materials 0.000 claims description 2
- 239000011669 selenium Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 2
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims 1
- 238000000227 grinding Methods 0.000 claims 1
- 239000004576 sand Substances 0.000 claims 1
- 235000016709 nutrition Nutrition 0.000 abstract description 22
- 230000000694 effects Effects 0.000 abstract description 19
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract description 16
- 230000035764 nutrition Effects 0.000 abstract description 12
- 239000000203 mixture Substances 0.000 abstract description 11
- 238000009472 formulation Methods 0.000 abstract description 10
- 210000004369 blood Anatomy 0.000 abstract description 9
- 239000008280 blood Substances 0.000 abstract description 9
- 230000001737 promoting effect Effects 0.000 abstract description 9
- 229910052757 nitrogen Inorganic materials 0.000 abstract description 8
- 208000024891 symptom Diseases 0.000 abstract description 8
- 230000036039 immunity Effects 0.000 abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 7
- 210000000952 spleen Anatomy 0.000 abstract description 3
- 230000000975 bioactive effect Effects 0.000 abstract description 2
- 206010000234 Abortion spontaneous Diseases 0.000 abstract 1
- 208000009233 Morning Sickness Diseases 0.000 abstract 1
- 208000034850 Vomiting in pregnancy Diseases 0.000 abstract 1
- 230000017531 blood circulation Effects 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 208000015994 miscarriage Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 208000000995 spontaneous abortion Diseases 0.000 abstract 1
- 238000005728 strengthening Methods 0.000 abstract 1
- 230000001502 supplementing effect Effects 0.000 abstract 1
- 230000006870 function Effects 0.000 description 19
- 235000010755 mineral Nutrition 0.000 description 19
- 206010047700 Vomiting Diseases 0.000 description 18
- 241000234314 Zingiber Species 0.000 description 17
- 239000012141 concentrate Substances 0.000 description 16
- 230000003169 placental effect Effects 0.000 description 16
- 230000036528 appetite Effects 0.000 description 15
- 235000019789 appetite Nutrition 0.000 description 15
- 241000229722 Perilla <angiosperm> Species 0.000 description 14
- 235000018102 proteins Nutrition 0.000 description 14
- 102000004169 proteins and genes Human genes 0.000 description 14
- 108090000623 proteins and genes Proteins 0.000 description 14
- 239000003814 drug Substances 0.000 description 13
- 230000008673 vomiting Effects 0.000 description 12
- 210000002784 stomach Anatomy 0.000 description 10
- 235000008504 concentrate Nutrition 0.000 description 9
- 210000003754 fetus Anatomy 0.000 description 9
- 239000000843 powder Substances 0.000 description 9
- 238000005516 engineering process Methods 0.000 description 8
- 238000000605 extraction Methods 0.000 description 8
- 235000019688 fish Nutrition 0.000 description 8
- 235000013312 flour Nutrition 0.000 description 8
- 238000003809 water extraction Methods 0.000 description 8
- 206010062717 Increased upper airway secretion Diseases 0.000 description 7
- 230000029087 digestion Effects 0.000 description 7
- 208000002173 dizziness Diseases 0.000 description 7
- 208000026435 phlegm Diseases 0.000 description 7
- 239000000341 volatile oil Substances 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 6
- 208000001848 dysentery Diseases 0.000 description 6
- 210000000936 intestine Anatomy 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- 230000028327 secretion Effects 0.000 description 6
- 230000012010 growth Effects 0.000 description 5
- 230000000968 intestinal effect Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000013589 supplement Substances 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 241000498779 Myristica Species 0.000 description 3
- 206010028813 Nausea Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000009395 breeding Methods 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 210000004347 intestinal mucosa Anatomy 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000008693 nausea Effects 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- KKOXKGNSUHTUBV-UHFFFAOYSA-N racemic zingiberene Natural products CC(C)=CCCC(C)C1CC=C(C)C=C1 KKOXKGNSUHTUBV-UHFFFAOYSA-N 0.000 description 3
- 150000003384 small molecules Chemical class 0.000 description 3
- 230000009469 supplementation Effects 0.000 description 3
- 239000011726 vitamin B6 Substances 0.000 description 3
- 239000011800 void material Substances 0.000 description 3
- 229930001895 zingiberene Natural products 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 108010022579 ATP dependent 26S protease Proteins 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 208000007848 Alcoholism Diseases 0.000 description 2
- 102000016938 Catalase Human genes 0.000 description 2
- 108010053835 Catalase Proteins 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 229920000858 Cyclodextrin Polymers 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 2
- 229920002774 Maltodextrin Polymers 0.000 description 2
- 239000005913 Maltodextrin Substances 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- 102000057297 Pepsin A Human genes 0.000 description 2
- 108090000284 Pepsin A Proteins 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 201000007930 alcohol dependence Diseases 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000003474 anti-emetic effect Effects 0.000 description 2
- 239000002111 antiemetic agent Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 210000004051 gastric juice Anatomy 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 229940118019 malondialdehyde Drugs 0.000 description 2
- 229940035034 maltodextrin Drugs 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- GSSMIHQEWAQUPM-AOLPDKKJSA-N ovalbumin peptide Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CN=CN1 GSSMIHQEWAQUPM-AOLPDKKJSA-N 0.000 description 2
- 230000000242 pagocytic effect Effects 0.000 description 2
- 229940111202 pepsin Drugs 0.000 description 2
- 230000008855 peristalsis Effects 0.000 description 2
- 206010036067 polydipsia Diseases 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 230000001228 trophic effect Effects 0.000 description 2
- 210000004916 vomit Anatomy 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- OJYLAHXKWMRDGS-UHFFFAOYSA-N zingerone Chemical compound COC1=CC(CCC(C)=O)=CC=C1O OJYLAHXKWMRDGS-UHFFFAOYSA-N 0.000 description 2
- KKOXKGNSUHTUBV-LSDHHAIUSA-N zingiberene Chemical compound CC(C)=CCC[C@H](C)[C@H]1CC=C(C)C=C1 KKOXKGNSUHTUBV-LSDHHAIUSA-N 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- 239000001169 1-methyl-4-propan-2-ylcyclohexa-1,4-diene Substances 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000244186 Ascaris Species 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 101000693916 Gallus gallus Albumin Proteins 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 108090000942 Lactalbumin Proteins 0.000 description 1
- 102000004407 Lactalbumin Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 206010028817 Nausea and vomiting symptoms Diseases 0.000 description 1
- 206010051986 Pneumatosis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 244000202052 Poncirus trifoliata Species 0.000 description 1
- 235000000404 Poncirus trifoliata Nutrition 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000019155 Radiation injury Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical compound Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000003005 anti-senility effect Effects 0.000 description 1
- 230000003457 anti-vomiting effect Effects 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 201000009361 ascariasis Diseases 0.000 description 1
- 229940065181 bacillus anthracis Drugs 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 210000003445 biliary tract Anatomy 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000915 fish venom Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- WWULHQLTPGKDAM-UHFFFAOYSA-N gamma-eudesmol Natural products CC(C)C1CC(O)C2(C)CCCC(=C2C1)C WWULHQLTPGKDAM-UHFFFAOYSA-N 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- NLDDIKRKFXEWBK-AWEZNQCLSA-N gingerol Chemical compound CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 NLDDIKRKFXEWBK-AWEZNQCLSA-N 0.000 description 1
- JZLXEKNVCWMYHI-UHFFFAOYSA-N gingerol Natural products CCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 JZLXEKNVCWMYHI-UHFFFAOYSA-N 0.000 description 1
- 235000002780 gingerol Nutrition 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 231100000731 ichthyotoxin Toxicity 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 210000002490 intestinal epithelial cell Anatomy 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 150000002561 ketenes Chemical class 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001175 peptic effect Effects 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- 150000007875 phellandrene derivatives Chemical class 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 235000014483 powder concentrate Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000021075 protein intake Nutrition 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 235000020985 whole grains Nutrition 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 125000000038 zingiberene group Chemical group 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A23L33/165—Complexes or chelates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pediatric Medicine (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Inorganic Chemistry (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明提供了一种供妊娠反应人群食用含短肽的特殊膳食用食品配方，该食品以食源性短肽为主要原料，添加生姜、乌梅、紫苏、砂仁、陈皮、丁香、肉豆蔻、枳椇子等药食两用中草药浓缩提取物，再辅以低聚糖、维生素和矿物质，组成复合配方。采用该食品配方可以制成粉状或颗粒状，以温开水溶解后食用。按照本发明配方制备的食品，易溶解，可快速吸收和利用，为机体提供优质氮源、多种维生素和矿物质，改善妊娠反应人群的营养状况和生理状况，通过食源性短肽、药食两用中草药浓缩提取物中的生物活性成分、低聚糖等多种因子的共同作用，可以辅助提高机体免疫力、健脾益气、固经安胎、滋阴补血、行气活血、辅助缓解孕吐症状等的作用，适合妊娠反应人群食用。
Description
技术领域
本发明涉及一种食品的配方，尤其是涉及一种以短肽补充蛋白质，补充维生素和矿物质，并利用药食两用中草药中的功能因子调节机体功能，适合妊娠初期妊娠反应人群食用的特殊膳食用食品的配方。
背景技术
在妊娠早期（停经六周左右）孕妇体内绒毛膜促性腺激素（HCG）增多，肾上腺皮质功能低下则其皮质激素分泌不足，从而使体内水及糖类代谢紊乱、胃酸分泌减少及胃排空时间延长，导致头晕乏力、食欲不振、喜酸食物或厌恶油腻恶心、晨起呕吐等一系列反应，统称为妊娠反应。
绝大部分妊娠（50%～90%）都有头晕乏力、食欲不振、恶心和呕吐的发生，一般从妊娠6～8周开始，到10～12周达到高峰，一半左右在妊娠14周前缓解，90%在妊娠22周前缓解。头晕乏力、食欲不振、恶心呕吐的治疗很少能够完全缓解症状，但可以明显减少相关的不适和不快。
妊娠初期，因为胚胎小，生长较慢，所以需要的营养不多，轻度的妊娠反应对孕妇和胎儿都没有什么影响，但是严重的妊娠反应，持续的时间又比较长，可能会给孕妇的健康和胎儿的生长发育带来不良影响。因为随着胎儿逐渐长大，需要的营养也越来越多，而严重的妊娠反应会使孕妇摄取不到足够的营养，母亲只有利用自己体内贮存的蛋白质、脂肪等来补充胎儿的需要，以至体重下降、消瘦、抵抗力降低。反应特别重的，还可能因发生脱水或酸中毒而威胁孕妇和胎儿的生命。
因此对于妊娠初期妊娠反应孕妇实施必要的营养补充，尤其是选择和补充无需肠胃消化人体可直接吸收的短肽类蛋白质，是对妊娠初期孕妇和胎儿进行有效营养支持的关键；同时，补充具有温和止吐、提振食欲功能的药食两用中草药，在有效缓解孕妇头晕乏力、食欲不振、恶心和呕吐症状的同时，有利于维持娠初期孕妇的氮平衡和正常的营养状态，改善机体机能状况，给妊娠初期孕妇及胎儿及时提供充足的营养。
现在国内外均提倡采用特殊营养食品，对妊娠反应人群等的特定人群进行营养补充和改善。这在美国、欧盟等发达国家已有开发和应用。美国食品药品监督管理局(FDA)将特殊营养食品定义为“医疗食品(medical foods)”。欧盟特殊膳食的委员会颁布指令(COMMISSION DIRECTIVE 1999/21/EC of 25 March 1999)将特殊营养食品定义为“以医疗为目的的特殊膳食”。我国将特殊营养食品命名为“特殊膳食用食品”，并在我国的《食品安全国家标准 孕妇及乳母营养补充食品》（GB 31601）及《食品安全国家标准 预包装特殊膳食用食品标签》(GB 13432)中规定，特殊膳食用食品是为满足某些特殊人群的生理需要，或某些疾病患者的营养需要，按特殊配方而专门加工的食品。因此，根据妊娠反应人群的代谢特点和营养需求，选择适宜的食物原料和营养素，制备供妊娠反应人群食用的特殊营养食品，用于改善妊娠反应人群的营养状况及生理状况，符合国家的政策导向和标准要求。
氮源的选择是妊娠初期妊娠反应人群营养支持的关键。科学研究证实，利用生物酶解方法从蛋白质中提取的短肽是一类小分子蛋白质，它不需消化即可吸收，并且在吸收过程中，载体不易饱和，耗能少，速度快，优于氨基酸和完整的蛋白质，是机体的优质氮源。
药食同源性食物在我国历史悠久，应用广泛。这类食物不仅可作为食物，为人体提供营养功能，而且还具有很高的药用价值，提供一定的治疗作用。国家卫生部于2002年颁布了“既是食品又是药品的物品名单(卫法监发[2002]51号)”，为传统中草药在食品中的应用提供的依据。
在专利文献中，也有一些专门针对妊娠初期妊娠反应人群的药品或保健食品，但根据专利文献和非专利文献，还未发现根据妊娠初期妊娠反应人群代谢特点和营养需求、以食源性短肽和传统药食同源食物为主要原料而制备的专门供妊娠初期妊娠反应人群食用的短肽特殊膳食营养食品。
发明内容
本发明的目的是根据妊娠初期妊娠反应人群的代谢特点和营养需求，结合妊娠初期妊娠反应人群营养支持的原则，提供了一种包含食源性生物活性短肽、传统的药食两用中草药、低聚糖、维生素和矿物质的特殊膳食用食品配方。该短肽特殊膳食用食品配方不仅可以补充妊娠初期妊娠反应人群需要的优质蛋白质、维生素、矿物质，不增加肝肾负担；同时可以有效缓解因妊娠初期妊娠反应所导致的头晕乏力、食欲不振、恶心和呕吐等症状，及时为孕妇和胎儿提供生长发育所需营养。本发明提出的短肽特殊膳食用食品适合妊娠初期妊娠反应人群食用。
本发明提出的特殊膳食用食品是以短肽为主要原料，再添加传统的药食两用中草药浓缩提取物、低聚糖、维生素、矿物质，组合成的复合配方。
本发明配方的主要成分为：
短肽：
本发明所述的短肽，即为低聚肽，是指利用生物酶工程技术从动物或植物蛋白中分离提取的一类小分子蛋白质。其平均分子量在1000Dalton以下，易溶于水，对酸、热稳定，可以不需经过消化而直接吸收，生物利用率高，在吸收和利用上优于游离的氨基酸和完整的蛋白质，可应用于蛋白质补充食品中。尤其对于消化和吸收能力减弱的人群，短肽是极佳的氮源。
除营养功能外，短肽还具有一系列的生理活性功能：
1.提高小肠的消化吸收功能。短肽可以改善小肠粘膜组织形态结构，增加小肠绒毛的高度和表面积，加深隐窝的深度，改善和维持肠壁粘膜细胞结构和功能的完整性。
2.增强机体免疫力。短肽可以增加巨噬细胞的吞噬率和吞噬指数，增强淋巴细胞的增殖能力，促进抗体形成细胞数量增加，提高机体的免疫水平。
3.抗氧化。短肽可以增加谷胱甘肽过氧化物酶(GSH-Px)、超氧化物歧化酶(SOD)、过氧化氢酶(CAT)的活性，降低脂质过氧化物丙二醛(MAD)的水平，从而发挥抗氧化功能。
4.辅助调节血糖。动物实验表明，短肽具有降低糖尿病大鼠空腹血糖水平的趋势，但对正常大鼠的空腹血糖水平无明显影响。
5.辅助调节血脂。短肽可以降低血清总胆固醇和低密度脂蛋白胆固醇的水平。
6.辅助降血压。
7.抗辐射。短肽有助于维持机体皮肤细胞结构和功能的完整性，减轻辐射损伤。
8.促进矿物质吸收。短肽在肠道内通过与矿物质如钙、铁、锌等的螯合，提高矿物质的转运比例，增加矿物质的吸收率。
9.增强药食两用中草药中功能因子的作用效果。短肽与中草药中的功能因子如活性多糖等具有协同作用，能够提高其增强机体免疫力、抗辐射的效果。
本发明所述的短肽是指海洋鱼低聚肽、大豆蛋白肽、乳清蛋白肽、卵白蛋白肽、海参肽、牡蛎肽、豌豆蛋白肽其中一种、几种或全部混合。
本发明所述的海洋鱼低聚肽是指以深海鱼(如三文鱼、鳕鱼等)的鱼皮、鱼骨、鱼肉为原料，利用生物酶解技术，提取的小分子蛋白质，其平均分子量低于1000Dalton。
本发明所述的大豆蛋白肽是指以大豆蛋白为原料，利用生物酶解技术，提取的小分子蛋白质，其平均分子量低于1000Dalton。
本发明所述的乳清蛋白肽是指以牛乳的乳清蛋白为原料，利用生物酶解技术，提取的小分子蛋白质，其平均分子量低于1000Dalton。
本发明所述的卵白蛋白肽是指以卵蛋白(如鸡蛋蛋白)为原料，利用生物酶解技术，提取的小分子蛋白质，其平均分子量低于1000Dalton。
本发明所述的海参肽是指以海参为原料，利用生物酶解技术，提取的小分子蛋白质，其平均分子量低于1000Dalton。
本发明所述的牡蛎肽是指以牡蛎为原料，利用生物酶解技术，提取的小分子蛋白质，其平均分子量低于1000Dalton。
本发明所述的豌豆蛋白肽是指以豌豆蛋白质为原料，利用生物酶解技术，提取的小分子蛋白质，其平均分子量低于1000Dalton。
药食两用中草药浓缩提取物：
生姜浓缩提取物：
生姜是具有解表散寒，温中止呕，温肺止咳，降温提神，增进食欲等功能的药食两用物品。据现代医学研究，生姜其有效成分为姜烯，具有保护胃黏膜细胞的作用．在芳香健胃生药中，特别是姜科植物中多含有姜烯等萜类精油成分，是健胃生药的有效成分之一，可显著抑制盐酸性和应激性胃黏膜损伤，使胃蛋白酶作用减弱，脂肪分解酶的作用增强。从生姜中浓缩提取出来的姜油酮及姜烯酮的混合物亦有止呕效果，生姜中含有姜醇、姜烯、水芹烯、柠檬醛和芳香等油性的挥发油，还有姜辣素、树脂、淀粉和纤维等，故其具有兴奋、排汗降温、提神等作用;可缓解疲劳、乏力、厌食、失眠、腹胀、腹痛等症状;生姜还有健胃,增进食欲的作用。
乌梅浓缩提取物：
乌梅有收敛生津、安蛔驱虫、增进食欲的功效，是具有可治虚热烦渴、久疟、呕吐等功能的药食两用物品。据现代医学研究，乌梅中含儿茶酸能促进肠蠕动，因此便秘之人宜食之；乌梅中含多种有机酸，有改善肝脏机能的作用，故肝病患者宜食之；乌梅中的梅酸可软化血管，推迟血管硬化，具有防老抗衰作用。《纲目》记载：乌梅可"敛肺涩肠，治久嗽，泻痢，反胃噎膈，蛔厥吐利，消肿，涌痰，杀虫，解鱼毒、马汗毒、硫黄毒"。《本草拾遗》记载：乌梅可"去痰，主疟瘴，止渴调中，除冷热痢，止吐逆。"
紫苏浓缩提取物：
紫苏具行气宽中，可用于治疗脾胃气滞、胸闷呕吐等症，有和胃止呕的功效，可用于妊娠呕吐、胎动不安、胸腹满闷，常与陈皮、砂仁配伍，服用后可达到止呕、安胎的效果。《本草纲目》记载：紫苏可“行气宽中，消痰利肺，和血，温中，止痛，定喘，安胎。”《滇南本草》记载：紫苏可“发汗，解伤风头痛，消痰，定吼喘。”《名医别录》记载：紫苏可“主下气，除寒中。”
砂仁浓缩提取物：
砂仁性温，味辛，具有行气调中、和胃醒脾的功效，用于湿浊中阻，腹痛痞胀，胃呆食滞，呕吐泻泄，妊娠恶阻，胎动不安等症。砂仁历史悠久，早在两千多年的宋代出版的药学著作《开元本草》中就首次记载了春砂仁的药物功效，云其可开胃醒酒食，安胎治恶阻，行气止痛，和中止痢。金元时期医家李东垣称春砂仁为化酒食之妙剂，因其辛温行气而使酒食随之而化。明代万历年间的《药鉴》称春砂仁为安胎之妙品。后世的各类医药方书中均有记载，把本品作为健胃行气，和中安胎，燥湿止泻的要药。
陈皮浓缩提取物：
陈皮具有理气降逆、调中开胃、燥湿化痰之功。主治脾胃气滞湿阻、胸膈满闷、脘腹胀痛、不思饮食、呕吐秽逆、二便不利、肺气阻滞、咳嗽痰多等症。陈皮所含挥发油，对胃肠道有温和的刺激作用，可促进消化液的分泌，排除肠管内积气；同时，陈皮所含挥发油有刺激性被动祛痰作用，使痰液易咯出。陈皮煎剂对支气管有微弱的扩张作用。其醇提物的平喘效价较高。
丁香浓缩提取物：
丁香为芳香健胃剂，可缓解腹部气胀，增加胃液分泌，增强消化能力，减轻恶心呕吐，水煎剂对葡萄球菌、链球菌、大肠杆菌、伤寒杆菌、绿脓杆菌等有抑制作用。丁香水浸物有刺激胃酸和胃蛋白酶的分泌、提高消化力的作用，并能抑制胃溃疡的发生。丁香水提取物及乙醚提取物有明显的抗炎、镇痛的作用，丁香酚还有镇静及明显的抗惊厥的作用，并能引起呼吸抑制。丁香醇浸出物对鼠疫杆菌、霍乱弧菌、炭疽杆菌、枯草杆菌及金黄色葡萄球菌等有抑制作用。丁香的水、醇、乙醚浸出液及挥发油对致病性真菌均呈非常明显的抗菌作用。
肉豆蔻浓缩提取物
肉豆蔻的性味辛：苦；温，可温中涩肠；行气消食。用于虚泻；冷痢；脘腹胀痛；食少呕吐；宿食不消。肉豆蔻所含挥发油，少量能促进胃液的分泌及胃肠蠕动，而有开胃和促进食欲，消胀止痛的功效。挥发油中的萜类成分对细菌和霉菌均有抑制作用。《药性论》记载:“能主小儿吐逆，不下乳，腹癀；治宿食不消，痰饮。”《梅药本草》记载:“主心腹虫痛，脾胃虚冷气并，冷热虚泄，赤白痢等。凡痢以白粥饮服佳；霍乱气井，以生姜荫服良。”《纲目》记载:“暖脾胃，固大脑。”
枳椇子浓缩提取物
枳椇子可清热利尿，止咳除烦，解酒毒，健胃，补血。用于中酒毒、烦渴呕逆、二便不利。《本草拾遗》记载：“止渴除烦，润五脏，利大小便，去膈上热，功用如蜜。”《纲目》记载：“止呕逆。”《滇南本草》记载：“治一切左瘫右痪，风湿麻木，能解酒毒；或泡酒服之，亦能舒筋络。小儿服之，化虫，养脾。”
本发明所述的药食两用中草药浓缩提取物为生姜浓缩提取物、乌梅浓缩提取物、紫苏浓缩皮提取物、砂仁浓缩提取物、陈皮浓缩提取物、丁香浓缩提取物、肉豆蔻浓缩提取物、枳椇子浓缩提取物其中的一种、数种或全部混合。
本发明所述的生姜浓缩提取物是指生姜干粉水提浓缩，将浓缩液喷雾干燥而制备的粉状物质。
本发明所述的乌梅浓缩提取物是指将乌梅干粉水提浓缩，将浓缩液喷雾干燥而制备的粉状物质。
本发明所述的紫苏浓缩提取物是指将紫苏干粉水提浓缩，将浓缩液喷雾干燥而制备的粉状物质。
本发明所述的砂仁浓缩提取物是指将砂仁干粉水提浓缩，将浓缩液喷雾干燥而制备的粉状物质。
本发明所述的陈皮浓缩提取物是指将陈皮干粉水提浓缩，将浓缩液喷雾干燥而制备的粉状物质。
本发明所述的丁香浓缩提取物是指将丁香干粉水提浓缩，将浓缩液喷雾干燥而制备的粉状物质。
本发明所述的肉豆蔻浓缩提取物是指将肉豆蔻干粉水提浓缩，将浓缩液喷雾干燥而制备的粉状物质。
本发明所述的枳椇子浓缩提取物是指将枳椇子干粉水提浓缩，将浓缩液喷雾干燥而制备的粉状物质。
低聚糖：
低聚糖，又称寡糖，是指由2～10个单糖通过糖苷键连接形成的直链或支链的低度聚合糖。功能性低聚糖不被人体消化吸收，也不被大多数的肠道腐败菌利用，但可以促进人体内有益细菌——双歧杆菌的生长繁殖，从而可以抑制腐败菌生长，有助于改善和维持肠道正常功能。长期食用可以延缓衰老、通便、提高免疫力、减轻肝脏负担、提高营养吸收率，特别是能够改善机体对钙、铁、锌离子的吸收。
本发明所述的低聚糖为低聚半乳糖、低聚异麦芽糖低聚果糖、大豆低聚糖、低聚木糖其中的一种、几种或全部混合。
维生素和矿物质：
维生素和矿物质是人体必需的营养素。本发明中添加的维生素为维生素A、维生素D、维生素E、维生素K、维生素C、维生素B1、维生素B2、维生素B6、维生素B12、烟酸、叶酸、泛酸、胆碱、生物素其中的一种、几种或全部混合。
本发明中添加的矿物质为钙、磷、钾、钠、镁、氯、铁、锌、硒、铜、锰、碘、钼其中的一种、几种或全部混合。本发明所述的矿物质添加为该矿物质的有机或无机化合物。
本发明中维生素矿物质的添加量参照《食品安全国家标准 孕妇及乳母营养补充食品》（GB 31601）和《食品安全国家标准 食品营养强化剂使用标准》(GB14880)执行。
上述各种配料混合均匀，可保持其粉状，或经过造粒，制成粉状或颗粒状食品。
本发明的技术优点：
本发明将现代营养学研究成果与传统养生保健理论相结合，研制了一种采用食源性活性短肽、药食两用中草药浓缩提取物、低聚糖、维生素和矿物质等混合配制的特殊膳食用食品。通过各种配料的有机组合，将各种功能进行融合，并通过有效成分之间的协同作用，增强作用效果。按本发明配方制作的食品可以有效补充妊娠初期妊娠反应人群所需营养，缓解因孕妇妊娠反应导致的头晕乏力、食欲不振、恶心和呕吐等症状，及时为孕妇和胎儿提供生长发育所需营养。
本配方食品的特性及其对机体的作用主要表现在以下几个方面：
1)食品具有等渗性
利用本发明配方，各种组分采用适宜的比例搭配制备的食品，经一定量的水溶解后呈等渗状态，能快速通过胃到达小肠，吸收快，无残渣，不增加胃肠及肝脏负担。所含氮源来自短肽，易于吸收利于，不增加肾脏负担。
2)发挥更好的营养效果
本发明配方食品以多种来源的短肽为氮源，因为短肽不需消化即可吸收，多种短肽形成平衡的氨基酸模式，更有利于机体的利用。可以在一定程度上改善妊娠反应人群负氮平衡。
本发明配方食品含多种维生素和矿物质，可迅速补充妊娠初期妊娠反应人群所需营养。短肽通过与钙、铁、锌等的螯合后，更增加了矿物质元素的吸收率。
3)有效缓解和平复食欲不振、恶心和呕吐等妊娠反应症状
本发明配方食品的生姜、乌梅、紫苏、砂仁、陈皮、丁香等中的生理活性物质具有增强食欲、增加胃液分泌、减轻恶心呕吐、安胎等功效。可有效缓解和平复食欲不振、恶心和呕吐等症状。
3)提高机体免疫力
本发明配方食品的生姜、乌梅、紫苏、砂仁、陈皮、丁香等生理活性物质具有增强抵抗力的作用、短肽可以提高机体免疫力、低聚糖通过促进肠道益生菌的生长繁殖也可以增强机体免疫力、短肽与活性多糖类物质具有协同作用。多个方面的因素联合，可以明显增强机体的抵抗能力。
4)改善胃肠道功能
短肽能够改善肠粘膜上皮细胞的结构和功能，提高肠粘膜的吸收能力。低聚糖通过促进肠内益生菌的生长繁殖，抑制腐败菌的生长，同时在肠粘膜表面形成一道保护屏障，可以抵御肠道腐败菌对肠粘膜的损伤，减少肠内有害物质的吸收。低聚糖可以促进肠道蠕动，加速肠内残留物质的排出，有利于防止便秘。
5)增强机体的抗氧化、抗辐射能力等。
6)本发明配方中采用各种药食两用中草药的浓缩提取物，提高了功能因子的浓度，减少各种杂质的摄入，有助于减轻肝肾负担。
具体实施方式：
以下通过实施例对本发明作进一步说明。
实施例1 制备供妊娠反应人群食用的短肽特殊膳食用食品“韵太宁”短肽复合营养素（妊娠反应人群适用）（固体饮料）
本实施例选择粉状的海洋鱼低聚肽、大豆蛋白肽、全脂乳粉、麦芽糊精、环状糊精、生姜浓缩提取物、乌梅浓缩提取物、紫苏浓缩提取物、砂仁浓缩提取物、低聚异麦芽糖及各种维生素和矿物质，按下列原料及其用量进行配方。
海洋鱼低聚肽1.75g 大豆蛋白肽0.7g
生姜浓缩提取物0.3g 乌梅浓缩提取物0.5g 紫苏浓缩提取物0.3g 砂仁浓缩提取物0.5g
低聚异麦芽糖0.7g
维生素A 140μg、维生素D 1.5μg、维生素C 110mg、维生素E 2μg、维生素B1 1.05mg、维生素B2 1.05mg、维生素B6 1.5mg、 维生素B12 1.5μg、烟酸2.5mg、叶酸70μg
钙150mg、铁4.5mg、锌2mg
将上述原料混合，搅拌均匀，经过干燥，制成粉状食品。用约150ml温开水溶解后，直接饮用。
目前该产品已上市销售，属于重庆市卫计委唯一批复的针对妊娠反应人群食用的特殊膳食食品（产品标准号：Q/KSK 0001 S-2016）,已在重庆、四川、广东、浙江、北京、上海等300余家三级医院及妇幼保健院销售给5000余名妊娠初期妊娠反应人群食用，医生和孕妇反映良好，有效解决娠初期妊娠反应人群营养补充不足及头晕乏力、食欲不振、恶心和呕吐等症状。
实施例2 制备供妊娠反应人群食用的短肽特殊膳食用食品“韵太宁”短肽复合营养素（妊娠反应人群适用）（颗粒）
本实施例选择粉状的海洋鱼低聚肽、大豆蛋白肽、全脂乳粉、麦芽糊精、环状糊精、生姜浓缩提取物、乌梅浓缩提取物、紫苏浓缩提取物、砂仁浓缩提取物、低聚异麦芽糖及各种维生素和矿物质，按下列原料及其用量进行配方。
海洋鱼低聚肽1.75g 大豆蛋白肽0.7g
生姜浓缩提取物0.3g 乌梅浓缩提取物0.5g 紫苏浓缩提取物0.3g 砂仁浓缩提取物0.5g
低聚异麦芽糖0.7g
维生素A 140μg、维生素D 1.5μg、维生素C 110mg、维生素E 2μg、维生素B1 1.05mg、维生素B2 1.05mg、维生素B6 1.5mg、 维生素B12 1.5μg、烟酸2.5mg、叶酸70μg
钙150mg、铁4.5mg、锌2mg
将上述原料混合，搅拌均匀，经过造粒、干燥，整粒，制成颗粒状。用约150ml温开水溶解后，直接饮用。
Claims (7)
1.一种供妊娠反应人群食用含短肽的特殊膳食用食品配方，其特征是以食源性生物活性短肽为主要原料，再添加传统的药食两用中草药浓缩提取物、低聚糖、维生素和矿物质，组成复合配方。
2.根据权利要求1所述的供妊娠反应人群含短肽的特殊膳食用食品配方，其特征是所述的短肽为海洋鱼低聚肽、大豆蛋白肽、乳清蛋白肽、海参肽、牡蛎肽、豌豆蛋白肽其中的一种、几种或者全部混合。
3.根据权利要求1所述的供妊娠反应人群含短肽的特殊膳食用食品配方，其特征是所述的药食两用中草药浓缩提取物为生姜浓缩提取物、乌梅浓缩提取物、紫苏浓缩提取物、砂仁浓缩提取物、陈皮浓缩提取物、丁香浓缩提取物、肉豆蔻浓缩提取物、枳椇子浓缩提取物其中的一种、几种或全部混合。
4.根据权利要求1所述的供妊娠反应人群含短肽的特殊膳食用食品配方，其特征是所述的低聚糖为低聚异麦芽糖、低聚果糖、低聚木糖、低聚半乳糖其中的一种、几种或全部混合。
5.根据权利要求1所述的供妊娠反应人群含短肽的特殊膳食用食品配方，其特征是所述的维生素为维生素A、维生素D、维生素E、维生素C、维生素B1、维生素B2、维生素B2、维生素B12、烟酸、叶酸其中的一种、几种或全部混合。
6.根据权利要求1所述的供妊娠反应人群含短肽的特殊膳食用食品配方，其特征在于：所述的矿物质为钙、磷、钾、钠、镁、氯、铁、锌、硒、铜、锰、碘其中的一种、几种或全部混合。
7.根据权利要求1所述的供妊娠反应人群含短肽的特殊膳食用食品配方，其特征在于按照所述配方混合制备成粉状或颗粒状食品。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710841208.XA CN107440107A (zh) | 2017-09-18 | 2017-09-18 | 一种供妊娠反应人群食用含短肽的特殊膳食用食品配方 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710841208.XA CN107440107A (zh) | 2017-09-18 | 2017-09-18 | 一种供妊娠反应人群食用含短肽的特殊膳食用食品配方 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107440107A true CN107440107A (zh) | 2017-12-08 |
Family
ID=60496814
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710841208.XA Pending CN107440107A (zh) | 2017-09-18 | 2017-09-18 | 一种供妊娠反应人群食用含短肽的特殊膳食用食品配方 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107440107A (zh) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107927797A (zh) * | 2017-12-11 | 2018-04-20 | 重庆市生物技术研究所有限责任公司 | 一种供肌肉衰减综合征人群食用含短肽的全营养食品配方 |
| CN108741061A (zh) * | 2018-04-10 | 2018-11-06 | 陕西三正医用营养有限公司 | 一种应用于孕期调理的特殊膳食食品及其制备方法 |
| CN109907324A (zh) * | 2019-03-14 | 2019-06-21 | 建昌帮药业有限公司 | 一种供妊娠反应人群食用的营养粥及其制备方法 |
| CN110801506A (zh) * | 2019-11-15 | 2020-02-18 | 烟台杰西医疗器械有限公司 | 一种防晕止吐糖 |
| CN110800996A (zh) * | 2019-11-07 | 2020-02-18 | 上海奥医高科技实业有限公司 | 一种妊娠呕吐专用型临床营养配方及其制备方法 |
| CN111876376A (zh) * | 2020-06-30 | 2020-11-03 | 芜湖职业技术学院 | 一种具有增强卵母细胞及胚胎发育成熟的紫苏多糖组合物 |
| CN117562979A (zh) * | 2023-11-20 | 2024-02-20 | 山东大学齐鲁医院 | 一种用于治疗子痫前期综合症的生物制剂 |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101530195A (zh) * | 2008-01-28 | 2009-09-16 | 中国食品发酵工业研究院 | 一种供产妇食用含短肽的特殊膳食用食品配方 |
| US20120114758A1 (en) * | 2010-06-17 | 2012-05-10 | James Elgin Rea | Beverage for pregnancy & lactation |
| DE202015100275U1 (de) * | 2015-01-22 | 2015-03-10 | Mibe Gmbh Arzneimittel | Nährstoffzubereitung zur Vitalisierung |
| CN105012523A (zh) * | 2015-07-29 | 2015-11-04 | 李艳青 | 一种食疗调理妊娠呕吐的配方及其制备方法 |
| CN105212205A (zh) * | 2014-05-28 | 2016-01-06 | 陈小磊 | 一种缓解孕妇呕吐的组合物及制备方法 |
| CN105326038A (zh) * | 2015-11-10 | 2016-02-17 | 劲膳美生物科技股份有限公司 | 孕妇孕吐全营养配方食品 |
| CN106492163A (zh) * | 2016-11-30 | 2017-03-15 | 王江波 | 一种治疗妊娠呕吐的中药配方 |
| CN106572691A (zh) * | 2014-08-20 | 2017-04-19 | 雀巢产品技术援助有限公司 | 妊娠前/出生前/出生后最佳营养体系、用于其中的组合物和套装产品及其制备和使用方法 |
-
2017
- 2017-09-18 CN CN201710841208.XA patent/CN107440107A/zh active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101530195A (zh) * | 2008-01-28 | 2009-09-16 | 中国食品发酵工业研究院 | 一种供产妇食用含短肽的特殊膳食用食品配方 |
| US20120114758A1 (en) * | 2010-06-17 | 2012-05-10 | James Elgin Rea | Beverage for pregnancy & lactation |
| CN105212205A (zh) * | 2014-05-28 | 2016-01-06 | 陈小磊 | 一种缓解孕妇呕吐的组合物及制备方法 |
| CN106572691A (zh) * | 2014-08-20 | 2017-04-19 | 雀巢产品技术援助有限公司 | 妊娠前/出生前/出生后最佳营养体系、用于其中的组合物和套装产品及其制备和使用方法 |
| DE202015100275U1 (de) * | 2015-01-22 | 2015-03-10 | Mibe Gmbh Arzneimittel | Nährstoffzubereitung zur Vitalisierung |
| CN105012523A (zh) * | 2015-07-29 | 2015-11-04 | 李艳青 | 一种食疗调理妊娠呕吐的配方及其制备方法 |
| CN105326038A (zh) * | 2015-11-10 | 2016-02-17 | 劲膳美生物科技股份有限公司 | 孕妇孕吐全营养配方食品 |
| CN106492163A (zh) * | 2016-11-30 | 2017-03-15 | 王江波 | 一种治疗妊娠呕吐的中药配方 |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107927797A (zh) * | 2017-12-11 | 2018-04-20 | 重庆市生物技术研究所有限责任公司 | 一种供肌肉衰减综合征人群食用含短肽的全营养食品配方 |
| CN108741061A (zh) * | 2018-04-10 | 2018-11-06 | 陕西三正医用营养有限公司 | 一种应用于孕期调理的特殊膳食食品及其制备方法 |
| CN109907324A (zh) * | 2019-03-14 | 2019-06-21 | 建昌帮药业有限公司 | 一种供妊娠反应人群食用的营养粥及其制备方法 |
| CN110800996A (zh) * | 2019-11-07 | 2020-02-18 | 上海奥医高科技实业有限公司 | 一种妊娠呕吐专用型临床营养配方及其制备方法 |
| CN110801506A (zh) * | 2019-11-15 | 2020-02-18 | 烟台杰西医疗器械有限公司 | 一种防晕止吐糖 |
| CN111876376A (zh) * | 2020-06-30 | 2020-11-03 | 芜湖职业技术学院 | 一种具有增强卵母细胞及胚胎发育成熟的紫苏多糖组合物 |
| CN117562979A (zh) * | 2023-11-20 | 2024-02-20 | 山东大学齐鲁医院 | 一种用于治疗子痫前期综合症的生物制剂 |
| CN117562979B (zh) * | 2023-11-20 | 2024-05-28 | 山东大学齐鲁医院 | 一种用于治疗子痫前期综合症的生物制剂 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107440107A (zh) | 一种供妊娠反应人群食用含短肽的特殊膳食用食品配方 | |
| CN107927797A (zh) | 一种供肌肉衰减综合征人群食用含短肽的全营养食品配方 | |
| CN101530195A (zh) | 一种供产妇食用含短肽的特殊膳食用食品配方 | |
| CN104738624A (zh) | 一种神经衰弱、健忘失眠的营养保健食品 | |
| CN107581599A (zh) | 一种供产妇自然分娩时食用含短肽的特殊膳食用食品配方 | |
| CN108095072A (zh) | 供长期卧床及肌肉衰减综合征人群食用短肽特膳食品配方 | |
| CN110432482A (zh) | 一种小儿过敏性皮炎专用型临床营养配方及其制备方法 | |
| CN104855994A (zh) | 肾病非全营养配方食品 | |
| CN105326038A (zh) | 孕妇孕吐全营养配方食品 | |
| CN104839695A (zh) | 炎性肠病非全营养配方食品 | |
| CN104856000A (zh) | 失眠非全营养配方食品 | |
| CN104855972A (zh) | 妇女延更调理非全营养配方食品 | |
| CN104855963A (zh) | 产妇产后调理非全营养配方食品 | |
| CN102511876B (zh) | 山楂红枣浓浆及其生产工艺 | |
| CN107410816A (zh) | 一种扶阳补元药食两用植物特膳食品 | |
| CN104855960A (zh) | 创伤感染手术及其它应急状态非全营养配方食品 | |
| CN103431396A (zh) | 一种解酒的天然植物含片及其制备工艺 | |
| CN108095075A (zh) | 流产女性专用型临床营养配方及其制备方法 | |
| CN102511882A (zh) | 一种有助于改善生长发育的红枣浓浆 | |
| CN106036880A (zh) | 一种缓解痛经的组合物及其应用和由其制成的健康食品 | |
| CN104187662A (zh) | 一种调理卵巢癌的方便食品 | |
| CN104855999A (zh) | 肾结石非全营养配方食品 | |
| CN104921100A (zh) | 调理黄褐斑非全营养配方食品 | |
| CN104855990A (zh) | 气郁体质非全营养配方食品 | |
| CN104855981A (zh) | 甲亢非全营养配方食品 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20171208 |